Welcome to this week’s edition of Weekend Wonderings. Grab whatever beverage that you need (coffee is nice, see above) and let’s proceed. We’ll have some news from The James, some miscellaneous commentary and wrap it up with a track by Eric Clapton.
Here is an interesting example of cross-fertilization between departments and between universities.
The Ohio State University and the University of Michigan have signed an exclusive worldwide agreement with Ohio-based Venture Therapeutics Inc., to form a new company to develop and commercialize a pharmaceutical technology targeted for the treatment of precancerous oral lesions.
Previously published data shows that about 30% of the higher grade precancerous oral lesions progress to oral cancer, specifically oral squamous cell carcinoma. This type of cancer is particularly devastating to patients because treatment entails removal of facial and mouth structures essential for esthetics and function. The National Cancer Institute estimates that 42,440 Americans will be diagnosed with oral cancer and over 8,390 oral cancer related deaths will occur in 2014.
This is a pretty big deal where OSU interdisciplines (dentistry and oncology) team up with UM staff for this new treatment protocol. Buckeyes and Wolverines may not care for one another on the field/court, but when it counts, it counts..